Shelter Pharma Ltd

BSE: 543963

12

total announcements

543963.BO · 15 min delayed

BSEOthersMgmt Change1 Sept 2026

Shelter Pharma Ltd

The Board of Directors of the Company at their meeting held on Tuesday, 01ST September, 2026 at 01:45 PM At the corporate office of the company at 5th Floor, 501 Sakar 4, Opp. MJ Library ....

Shelter Pharma Ltd's Board of Directors has approved the regularization of Ms. Vinita Shivraj Gadhavi as a Non-Executive Independent Director for a term of five consecutive years, re-appointment of Mrs. Parvezbanu Mohamed Rafiq Idariya as a Director, and other matters.

Read more →📎 1 attachment
BSECompany Update▲ PositiveProduct Launch21 Aug 2026

Shelter Pharma Ltd

Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015- New Product Launch

Shelter Pharma Ltd has launched a new Ayurvedic Herbal Human Healthcare product, SHELTIDIN DS, a cough spray for fast and effective relief from dry and irritating cough, sore throat, throat irritation, hoarseness of voice, and everyday throat discomfort. The product is available on reputed e-commerce platforms from 20th August, 2026.

Read more →📎 1 attachment
BSECompany Update▲ PositiveOrder Win27 Jul 2026

Shelter Pharma Ltd

Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015-Receipt of Significant International Purchase Orders.

Shelter Pharma Ltd has received significant international purchase orders from Genet International for Veterinary Feed Supplements products, valued at USD 12,285, which is expected to strengthen the company's global presence and contribute positively to its revenue growth and overall business expansion.

Read more →📎 1 attachment